The animal models market size is anticipated to develop at a high CAGR of 6.6% to reach US$ 2.4 billion by 2028 from US$ 1.7 billion in 2022.
The animal model market has witnessed substantial growth and continues to be a crucial tool in biomedical research and drug development. Animal models, including mice, rats, zebrafish, and non-human primates, play a pivotal role in understanding human diseases, evaluating the efficacy and safety of potential therapies, and advancing our knowledge of biology and genetics. As the pharmaceutical and biotechnology industries strive to bring innovative treatments to market, the demand for animal models remains robust. Moreover, the increasing prevalence of chronic diseases, such as cancer, cardiovascular disorders, and neurological conditions, has spurred research activities, further driving the growth of the animal model market.
Get a Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-3141
In recent years, advancements in genetic engineering techniques, such as CRISPR-Cas9, have enabled researchers to create highly customized animal models with specific genetic mutations, making them even more valuable in the study of diseases with a genetic component. Additionally, the growing focus on personalized medicine has led to a surge in the use of animal models to develop therapies tailored to individual patients. However, ethical concerns surrounding the use of animals in research, coupled with the development of alternative in vitro and in silico models, pose challenges to the animal model market. Nonetheless, the market is anticipated to continue its upward trajectory as researchers seek to unlock the complexities of human biology and develop novel treatments for a wide range of diseases.
Leveraging Animal Models offers Better Understanding of Different Diseases
Animals and human beings share a common biological as well as physiological structure. Animals possess shorter life cycle, however they have high genotype resemblance. It is simple and easy to control the animal environment as compared to the human beings.
The animal models are increasingly being used in the biomedical research that helps to develop new treatment methods for various diseases. Leveraging animal models offers a better understanding of different diseases, along with the efficacy of drugs with regard to the diseases.
Owing to these factors, demand for animal models has been witnessing a significant surge in the healthcare sector. Alternatives such as cell cultures, tissue cultures, and computer models are also available, however animal models are more preferred owing to the complexity of the living systems. This further makes animal models an effective choice for biomedical research.
Development of animal models, which are more predictive in being effective is an iterative process. However, progress is being made, with researchers applying new experimental approaches to elucidate the biology of specific diseases for the creating of new and efficient animal models.
During the development of new drugs dedicated to complex diseases, researchers are being well advised for testing drugs in multiple animal models as well as in mouse strains with different genetic backgrounds.
Researchers are also focusing on employing translational efficacy or pharmacodynamic biomarkers for linking efficacy observed in clinical results with pre-clinical analyses.
Unlock exclusive insights with our expert analysts: https://www.futuremarketinsights.com/ask-question/rep-gb-3141
Key Takeaways from FMI’s Report on Global Animal Model Market
- North America is expected to remain the largest and fastest expanding market for animal model, with revenues estimated to surpass US$ 800 Mn by 2026-end. Between animal model markets in Asia-Pacific and Europe, the former will account for relatively larger revenue share, whereas the latter will expand at a comparatively higher CAGR through 2026. Although the market in South Korea will account for the lowest market revenue share, revenues are projected to expand at a relatively higher CAGR than those from the markets in Latin America and Middle East & Africa (MEA) through 2026.
- On the basis of species, revenues from rats and mice are projected to account for over two-fifth share of the market by 2026-end. Revenues from use of rats in animal models will expand at the highest CAGR in the market through 2026. In addition, revenues from use of cats and monkeys in animal models will rise at a nearly equal CAGR through 2026. Dogs and pigs are expected to remain the least lucrative species used in animal models during the forecast period.
- Contract research organizations (CROs) and biotechnology companies are anticipated to remain the fast expanding end-users of animal models. Revenues from these two end-users are collectively forecast to surpass US$ 850 Mn by 2026-end. In terms of revenues, academic & research institutions and pharmaceutical companies will continue to be dominant end-users in the global animal model market.
Unlock Tailored Insights: Customize Your Report for Maximum Impact:https://www.futuremarketinsights.com/customization-available/rep-gb-3141
- Basic and applied research application of animal model will continue to register the fastest expansion through 2026. However, drug discovery/development will remain the most lucrative application of animal model.
- Key companies actively contributing to growth of the global animal model market include Transposagen Biopharmaceuticals, Inc., Envigo CRS SA, Crown Bioscience, Inc., Eurofins Scientific SE, Genoway SA, Taconic Biosciences, Inc., Trans Genic Inc, The Jackson Laboratory, Horizon Discovery Group plc, and Charles River Laboratories International, Inc.
Key Segments:
Animal Model Market by Species:
- Rats
- Mice
- Guinea Pigs
- Rabbits
- Monkeys
- Dogs
- Pigs
- Cats
- Other Species
Animal Model Market by End User:
- Academic & Research Institutions
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Other End Users
Animal Model Market by Application:
- Basic and Applied Research
- Drug Discovery/Development
Animal Model Market by Region:
- North America Animal Model Market
- Latin America Animal Model Market
- Europe Animal Model Market
- East Asia Animal Model Market
- South Asia & Pacific Animal Model Market
- Middle East & Africa (MEA) Animal Model Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube